2022 Q3 Form 10-Q Financial Statement

#000151862122000083 Filed on August 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $35.61M $35.27M $41.86M
YoY Change 4.22% 20.56% 55.86%
Cost Of Revenue $21.36M $10.81M $5.289M
YoY Change 473.3% 222.91% 48.57%
Gross Profit -$79.30M -$57.83M -$146.7M
YoY Change -387.76% 287.11% 433.32%
Gross Profit Margin -222.68% -163.96% -350.39%
Selling, General & Admin $5.218M $4.944M $4.697M
YoY Change 42.03% 32.94% 34.47%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.218M $4.944M $4.697M
YoY Change 42.03% 32.94% 34.47%
Operating Profit -$84.51M -$62.77M -$151.4M
YoY Change -453.88% 236.44% 388.37%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$84.51M -$60.14M -$148.7M
YoY Change -424.58% 256.59% 406.39%
Income Tax
% Of Pretax Income
Net Earnings -$84.51M -$60.14M -$148.7M
YoY Change -424.58% 256.59% 406.41%
Net Earnings / Revenue -237.33% -170.52% -355.32%
Basic Earnings Per Share -$2.40 -$0.34 -$4.20
Diluted Earnings Per Share -$2.40 -$339.7K -$840.3K
COMMON SHARES
Basic Shares Outstanding 176.3M shares 177.0M shares 177.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $281.0M $219.0M $297.2M
YoY Change -33.76% -19.74% 40.61%
Cash & Equivalents $214.2M $219.0M $297.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $13.68M
Other Receivables $10.53M
Total Short-Term Assets $238.4M $232.9M $312.1M
YoY Change -45.74% -18.39% -17.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.237B $3.977B $4.617B
YoY Change -42.59% -14.86% 6.42%
Other Assets $66.77M $64.40M $130.2M
YoY Change 30.64% -39.75% 11.09%
Total Long-Term Assets $3.567B $4.241B $4.875B
YoY Change -37.83% -12.05% 7.07%
TOTAL ASSETS
Total Short-Term Assets $238.4M $232.9M $312.1M
Total Long-Term Assets $3.567B $4.241B $4.875B
Total Assets $3.806B $4.474B $5.187B
YoY Change -38.39% -12.4% 5.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.075M $1.138M $1.066M
YoY Change 14.97% 43.32% 52.29%
Accrued Expenses $4.424M $3.940M $1.018M
YoY Change 487.52% 278.12% 13.11%
Deferred Revenue
YoY Change
Short-Term Debt $3.134B $3.759B $4.464B
YoY Change -39.89% -16.74% 6.75%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.145B $3.772B $4.474B
YoY Change -41.83% -16.63% 1.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $260.5M $196.0M $120.8M
YoY Change 545.58% 555.42% 110.5%
Total Long-Term Liabilities $260.5M $196.0M $120.8M
YoY Change 545.58% 555.42% 110.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.145B $3.772B $4.474B
Total Long-Term Liabilities $260.5M $196.0M $120.8M
Total Liabilities $3.405B $3.968B $4.595B
YoY Change -37.47% -12.87% 2.92%
SHAREHOLDERS EQUITY
Retained Earnings -$376.1M -$291.6M
YoY Change 884.9%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $400.4M $506.4M $592.4M
YoY Change
Total Liabilities & Shareholders Equity $3.806B $4.474B $5.187B
YoY Change -38.39% -12.4% 5.21%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$84.51M -$60.14M -$148.7M
YoY Change -424.58% 256.59% 406.41%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $106.0M $70.49M $114.2M
YoY Change 370.35% 407.58% 361.06%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $540.6M $516.8M $1.674B
YoY Change -169.39% -228.66% -352.74%
Cash From Investing Activities $540.6M $516.8M $1.674B
YoY Change -169.39% -228.66% -352.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $214.0K
YoY Change -100.22%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -649.1M -731.3M -1.811B
YoY Change -176.17% -266.64% -371.68%
NET CHANGE
Cash From Operating Activities 106.0M 70.49M $114.2M
Cash From Investing Activities 540.6M 516.8M $1.674B
Cash From Financing Activities -649.1M -731.3M -1.811B
Net Change In Cash -2.419M -144.1M $1.788B
YoY Change -102.53% -381.82% 6048.27%
FREE CASH FLOW
Cash From Operating Activities $106.0M $70.49M $114.2M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283371000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.18
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2022Q2 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
36302000 usd
CY2021Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
37175000 usd
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
13932000 usd
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
18859000 usd
CY2022Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3758980000 usd
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
6244106000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
77125000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
56110000 usd
us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
10835000 usd
us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
3497000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
66290000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
52613000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-66529000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-6045000 usd
CY2022Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-15443000 usd
CY2021Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
1352000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-480560000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-96147000 usd
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
281574000 usd
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
10557000 usd
CY2021Q2 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-34915000 usd
orc Net Portfolio Income
NetPortfolioIncome
-199225000 usd
orc Net Portfolio Income
NetPortfolioIncome
-39022000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
5265000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
3413000 usd
us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
960000 usd
us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
799000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
551000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
625000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
621000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
595000 usd
us-gaap Professional Fees
ProfessionalFees
606000 usd
us-gaap Professional Fees
ProfessionalFees
620000 usd
orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
1217000 usd
orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
715000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
421000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
445000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9641000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7212000 usd
us-gaap Profit Loss
ProfitLoss
-208866000 usd
us-gaap Profit Loss
ProfitLoss
-46234000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177015963 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92456082 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99489065 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.290
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.390
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76073000 shares
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-29369000 usd
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17226000 usd
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18248000 shares
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
96908000 usd
CY2021Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
90000 shares
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
572000 usd
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
94411000 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
466176000 usd
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
20416000 usd
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
23087000 shares
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
124746000 usd
CY2021Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
2000 shares
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
180000 usd
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
117500000 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
553821000 usd
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
176993000 shares
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-148727000 usd
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
27492000 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
124000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
177117000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
592418000 usd
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
23936000 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
10000 shares
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
237000 usd
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
876000 shares
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-2218000 usd
us-gaap Profit Loss
ProfitLoss
-208866000 usd
us-gaap Profit Loss
ProfitLoss
-46234000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-66529000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-6045000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-480560000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-96147000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
161731000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
13483000 usd
orc Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
1934606000 usd
orc Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
1680903000 usd
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-167307000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2190809000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2218000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
orc Shares Withheld From Share Awards
SharesWithheldFromShareAwards
223000 usd
orc Shares Withheld From Share Awards
SharesWithheldFromShareAwards
299000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-167071000 usd
CY2022Q2 orc Securities Sold Settled In Later Period
SecuritiesSoldSettledInLaterPeriod
0 usd
CY2021Q2 orc Securities Sold Settled In Later Period
SecuritiesSoldSettledInLaterPeriod
154977000 usd
CY2021Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
37200000 usd
orc Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
1934606000 usd
orc Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
1680903000 usd
orc Investment Sales Carrying Value
InvestmentSalesCarryingValue
-2001135000 usd
orc Investment Sales Carrying Value
InvestmentSalesCarryingValue
-1686948000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-66529000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-6045000 usd
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
2705000 usd
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
4890000 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
-69234000 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
-10935000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-66529000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-6045000 usd
CY2022Q2 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
3939397000 usd
CY2022Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3758980000 usd
CY2022Q2 orc Cost Basis
CostBasis
20527000 usd
CY2022Q2 orc Assets Pledged To Counterparties
AssetsPledgedToCounterparties
4040110000 usd
CY2022Q2 orc Market Value Of Tba Contract
MarketValueOfTbaContract
21889000 usd
CY2022Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
1362000 usd
CY2022Q2 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
36300000 usd
CY2022Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0136 pure
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
6525175000 usd
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
6244106000 usd
CY2021Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0015 pure
CY2022Q2 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
0 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
514059000 usd
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
281574000 usd
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
10557000 usd
CY2021Q2 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-34915000 usd
CY2021Q4 orc Assets Pledged To Counterparties
AssetsPledgedToCounterparties
6620228000 usd
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100828173 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.10 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
7366623 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-208866000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-46234000 usd
orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
176251000 shares
orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
117500000 shares
orc Effect Of Weighting
EffectOfWeighting
765000 shares
orc Effect Of Weighting
EffectOfWeighting
-25044000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177016000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92456000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99489000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
466000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
251000 shares

Files In Submission

Name View Source Status
0001518621-22-000083-index-headers.html Edgar Link pending
0001518621-22-000083-index.html Edgar Link pending
0001518621-22-000083.txt Edgar Link pending
0001518621-22-000083-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orc-20220630.xsd Edgar Link pending
orc-20220630_cal.xml Edgar Link unprocessable
orc-20220630_def.xml Edgar Link unprocessable
orc-20220630_lab.xml Edgar Link unprocessable
orc-20220630_pre.xml Edgar Link unprocessable
orc10q20220630.htm Edgar Link pending
orc10q20220630p1i0.gif Edgar Link pending
orc10q20220630x311.htm Edgar Link pending
orc10q20220630x312.htm Edgar Link pending
orc10q20220630x321.htm Edgar Link pending
orc10q20220630x322.htm Edgar Link pending
orc10q20220630_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending